Literature DB >> 20978658

Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy.

Mateusz Kwitniewski1, Johan Moan, Asta Juzeniene.   

Abstract

For the first time we present data showing that metabolic targeted therapy with dichloroacetate (DCA) may improve the outcome of photodynamic therapy. This treatment modality can be easily introduced into clinical practice guidelines.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20978658     DOI： 10.1039/c0pp00193g

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN： 1474-905X            Impact factor:   3.982


  4 in total

1.  Radical pleurectomy and photodynamic therapy for malignant pleural mesothelioma.

Authors:  Joseph S Friedberg
Journal:  Ann Cardiothorac Surg       Date:  2012-11

2.  Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines.

Authors:  Tatjana P Harting; Mandy Stubbendorff; Susanne C Hammer; Patrik Schadzek; Anaclet Ngezahayo; Hugo Murua Escobar; Ingo Nolte
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

3.  Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines.

Authors:  Franziska Weiner; Jan Torben Schille; Jens Ingo Hein; Xiao-Feng Wu; Matthias Beller; Christian Junghanß; Hugo Murua Escobar; Ingo Nolte
Journal:  PLoS One       Date:  2021-08-25       Impact factor: 3.240

4.  Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line.

Authors:  Katharina Klose; Eva-Maria Packeiser; Petra Müller; José Luis Granados-Soler; Jan Torben Schille; Sandra Goericke-Pesch; Manfred Kietzmann; Hugo Murua Escobar; Ingo Nolte
Journal:  PLoS One       Date:  2021-09-27       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.